Gestational trophoblastic neoplasia epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Choriocarcinoma}} | {{Choriocarcinoma}} | ||
{{CMG}}{{AE}}{{MD}} | {{CMG}}{{AE}}{{MD}} | ||
The incidence is approximately 110-120 per 100,000 pregnancies. | |||
==Epidemiology and Demographics== | |||
* The reported incidence in the United States is about 110 to 120 per 100,000 pregnancies. | * The reported incidence in the United States is about 110 to 120 per 100,000 pregnancies. | ||
* The reported incidence of choriocarcinoma, the most aggressive form of GTD, in the United States is about 2 to 7 per 100,000 pregnancies. | * The reported incidence of choriocarcinoma, the most aggressive form of GTD, in the United States is about 2 to 7 per 100,000 pregnancies. | ||
Revision as of 15:29, 14 October 2015
Template:Choriocarcinoma Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2] The incidence is approximately 110-120 per 100,000 pregnancies.
Epidemiology and Demographics
- The reported incidence in the United States is about 110 to 120 per 100,000 pregnancies.
- The reported incidence of choriocarcinoma, the most aggressive form of GTD, in the United States is about 2 to 7 per 100,000 pregnancies.
- The U.S. age-standardized (1960 World Population Standard) incidence rate of choriocarcinoma is about 0.18 per 100,000 women between the ages of 15 years and 49 years.